• Search History (Register)
  • MeSH Browser
    • Afrikaans
      Albanian
      Arabic
      Armenian
      Basque
      Bengali
      Bulgarian
      Catalan
      Cambodian
      Chinese (Mandarin)
      Chinese (Cantonese)
      Croatian
      Czech
      Danish
      Dutch
      English
      Estonian
      Fiji
      Finnish
      French
      Georgian
      German
      Greek
      Gujarati
      Hebrew
      Hindi
      Hungarian
      Icelandic
      Indonesian
      Irish
      Italian
      Japanese
      Javanese
      Korean
      Latin
      Latvian
      Lithuanian
      Macedonian
      Malay
      Malayalam
      Maltese
      Maori
      Marathi
      Mongolian
      Nepali
      Norwegian
      Persian
      Polish
      Portuguese
      Punjabi
      Quechua
      Romanian
      Russian
      Samoan
      Serbian
      Slovak
      Slovenian
      Spanish
      Swahili
      Swedish
      Tamil
      Tatar
      Telugu
      Thai
      Tibetan
      Tonga
      Turkish
      Ukrainian
      Urdu
      Uzbek
      Vietnamese
      Welsh
      Xhosa
      Apply
    • Adelaide Health Technology Assessment
      Agence d'évaluation des technologies et des modes d'intervention en santé
      Agencia de Evaluacion de Tecnologias Sanitarias
      Agència de Qualitat i Avaluació Sanitàries de Catalunya (AQuAS)
      Agencia de Qualitat i Avaluacio Sanitries de Catalunya
      Agency for Care Effectiveness (ACE)
      Agency for Health Technology Assessment and Tariff System
      Agency for Healthcare Research and Quality
      Agenzia Sanitaria e Sociale Regionale (Regional Agency for Health and Social Care)
      All Wales Medicines Strategy Group
      Andalusian Health Technology Assessment Area
      Australian Health Technology Advisory Committee
      Australian Safety and Efficacy Register of New Interventional Procedures-Surgical
      Austrian Institute for Health Technology Assessment
      Basque Office for Health Technology Assessment
      Belgian Health Care Knowledge Centre
      BlueCross BlueShield Association
      British Columbia Office of Health Technology Assessment
      Canadian Agency for Drugs and Technologies in Health
      Canadian Coordinating Office for Health Technology Assessment
      Canadian Task Force on Preventive Health Care
      Canary Health Service
      Cellule Innovation of the AP-HP
      Center for Drug Evaluation
      Center for Medical Technology Assessment
      Center for Outcomes Research and Economic Evaluation for Health
      Centre for Clinical Effectiveness
      Centre for Reviews and Dissemination
      Centre for Technology Assessment at the Swiss Science and Technology Council
      Centre Hospitalier de l'Universite de Montreal
      Centre intégré universitaire de santé et de services sociaux de la Capitale-Nationale
      Committee for New Health Technology Assessment
      Conseil d'Evaluation des Technologies de la Santé du Québec
      Coordenação-Geral de Fomento à Pesquisa e Avaliação de Tecnologias em Saúde, Departamento de Ciência e Tecnologia
      Danish Centre for Evaluation and Health Technology Assessment
      Danish Institute for Health Services Research
      ECRI Institute
      European Network for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Finnish Coordinating Center for Health Technology Assessment
      Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore
      German Agency for HTA at the German Institute for Medical Documentation and Information
      Gesundheit Osterreich GmbH
      Hannover Medical School, Medizinische Hochschule Hannover
      Haute Autorité de Santé
      HAYES, Inc.
      Health Council of the Netherlands Gezondheidsraad
      Health Information and Quality Authority (HIQA)
      Health Intervention and Technology Assessment Program
      Health Quality Ontario
      Health Sciences Institute in Aragon (IACS)
      Health Services Assessment Collaboration
      Health Services Utilization and Research Commission
      Health Technology Advisory Committee
      Health Technology and Policy Unit
      Health Technology Assessment Section, Ministry of Health Malaysia
      Health Technology Board for Scotland
      Health Technology Reference Group
      Health Technology Wales
      HTA Region Stockholm
      HTA South
      HTA Unit, University of Calgary
      Institut national d'excellence en sante et en services sociaux
      Institut universitaire de cardiologie et de pneumologie de Québec – Université Laval (IUCPQ-ULaval)
      Institute for Clinical and Economic Review
      Institute for Clinical Effectiveness and Health Policy
      Institute for Clinical Evaluative Sciences
      Institute for Clinical Systems Improvement
      Institute for Quality and Efficiency in Health Care (IQWiG)
      Institute of Applied Health Sciences
      Institute of Health Economics
      Institute of Health Economics
      Institute of Health Technology Assessment and Research (IETSI)
      Institute of Technology Assessment
      Israel Center for Technology Assessment in Health Care
      L'Agence Nationale d'Accreditation d'Evaluation en Santé
      Ludwig Boltzmann Institute for Health Technology Assessment
      Malaysian Health Technology Assessment
      Malaysian Health Technology Assessment Unit
      Medical Advisory Secretariat
      Medical Services Advisory Committee
      Monash Business School, Monash University (MBS)
      National Authority for Assessment and Accreditation in Healthcare (INEAS)
      National Committee for Technology Incorporation (CONITEC)
      National Evidence-based healthcare Collaborating Agency
      National Institute for Clinical Excellence
      National Institute for Health and Care Excellence
      New Zealand Health Technology Assessment
      New Zealand National Health Committee
      NIHR Health and Social Care Delivery Program
      NIHR Health Services and Delivery Research programme
      NIHR Health Technology Assessment programme
      NIHR Horizon Scanning Centre
      NIHR Public Health Research programme
      Norwegian Institute of Public Health
      Norwegian Institute of Public Health
      Norwegian Medical Products Agency
      Ontario Health
      Penn Medicine Center for Evidence-based Practice
      Quality Improvement Scotland
      Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS)
      Scottish Health Purchasing Information Centre
      Scottish Health Technologies Group
      Scottish Medicines Consortium (SMC)
      State Health Care Accreditation Agency under the Ministry of Health of the Republic of Lithuania
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swedish Agency for Health Technology Assessment and Assessment of Social Services
      Swiss Federal Office of Public Health (FOPH)
      Technology Assessment at SickKids
      Technology Assessment Unit of the McGill University Health Centre (MUHC)
      The Danish Health Technology Council
      The Federal Joint Committee
      The HTA Center of the Stockholm County Council/Gotland
      The Italian National Agency for Regional Health Services (Agenas)
      The National Health Care Institute (ZIN, Zorginstituut Nederland)
      The National Health Care Institute (Zorginstituut Nederland)
      The Netherlands Organisation for Health Research and Development
      The Regional Health Technology Assessment Centre
      TNO
      U. S. Congress. Office of Technology Assessment
      Unidad de Evaluacion de Tecnologias Sanitarias
      Unidad de Tecnologias de Salud
      Unit of Health Economics and Technology Assessment in Health Care
      University HealthSystem Consortium
      University of York
      VA Technology Assessment Program
      Washington Singer Press
      Washington State Department of Labor and Industries (WSDLI)
      Wessex Institute for Health Research and Development
      West Midlands Health Technology Assessment Collaboration
      WorkSafeBC
      Apply
    • Afghanistan
      Albania
      Algeria
      Andorra
      Antigua and Barbuda
      Argentina
      Armenia
      Australia
      Austria
      Azerbaijan
      Bahamas
      Bahrain
      Bangladesh
      Barbados
      Belarus
      Belgium
      Belize
      Benin
      Bhutan
      Bolivia
      Bosnia and Herzegovina
      Botswana
      Brazil
      Brunei
      Bulgaria
      Burkina Faso
      Burundi
      Cambodia
      Cameroon
      Canada
      Cape Verde
      Central African Republic
      Chad
      Chile
      China
      Colombia
      Comoros
      Congo
      Costa Rica
      Cote dIvoire
      Croatia
      Cuba
      Cyprus
      Czech Republic
      Denmark
      Djibouti
      Dominica
      Dominican Republic
      East Timor
      Ecuador
      Egypt
      El Salvador
      Equatorial Guinea
      Eritrea
      Estonia
      Ethiopia
      Fiji
      Finland
      France
      Gabon
      Gambia
      Georgia
      Germany
      Ghana
      Greece
      Grenada
      Guatemala
      Guinea
      Guinea-Bissau
      Guyana
      Haiti
      Honduras
      Hong Kong
      Hungary
      Iceland
      India
      Indonesia
      Iran
      Iraq
      Ireland
      Israel
      Italy
      Jamaica
      Japan
      Jordan
      Kazakhstan
      Kenya
      Kiribati
      North Korea
      South Korea
      Kuwait
      Kyrgyzstan
      Laos
      Latvia
      Lebanon
      Lesotho
      Liberia
      Libya
      Liechtenstein
      Lithuania
      Luxembourg
      Macedonia
      Madagascar
      Malawi
      Malaysia
      Maldives
      Mali
      Malta
      Marshall Islands
      Mauritania
      Mauritius
      Mexico
      Micronesia
      Moldova
      Monaco
      Mongolia
      Montenegro
      Morocco
      Mozambique
      Myanmar
      Namibia
      Nauru
      Nepal
      Netherlands
      New Zealand
      Nicaragua
      Niger
      Nigeria
      Norway
      Oman
      Pakistan
      Palau
      Panama
      Papua New Guinea
      Paraguay
      Peru
      Philippines
      Poland
      Portugal
      Puerto Rico
      Qatar
      Romania
      Russia
      Rwanda
      Saint Kitts and Nevis
      Saint Lucia
      Saint Vincent and the Grenadines
      Samoa
      San Marino
      Sao Tome and Principe
      Saudi Arabia
      Senegal
      Serbia and Montenegro
      Seychelles
      Sierra Leone
      Singapore
      Slovakia
      Slovenia
      Solomon Islands
      Somalia
      South Africa
      Spain
      Sri Lanka
      Sudan
      Suriname
      Swaziland
      Sweden
      Switzerland
      Syria
      Taiwan
      Tajikistan
      Tanzania
      Thailand
      Togo
      Tonga
      Trinidad and Tobago
      Tunisia
      Turkey
      Turkmenistan
      Tuvalu
      Uganda
      Ukraine
      United Arab Emirates
      United Kingdom
      United States
      Uruguay
      Uzbekistan
      Vanuatu
      Vatican City
      Venezuela
      Vietnam
      Yemen
      Zambia
      Zimbabwe
      Apply

Welcome to the international HTA database

CSV RIS
Showing [23371 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2011     NIHR Health Technology Assessment programme VenUS III: a randomised controlled trial of therapeutic ultrasound in the management of venous leg ulcers
2011     NIHR Health Technology Assessment programme Denosumab for osteoporotic fractures in post menopausal women primary and secondary prevention
2011     Medical Advisory Secretariat (MAS) Corneal collagen cross-linking using riboflavin and ultraviolet-A for corneal thinning disorders
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Corifollitropin alfa (Elonva®) for controlled ovarian stimulation in assisted human reproductive techniques]
2011     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Bioabsorbable everolimus-eluting coronary stent (BVS) for treatment of coronary artery disease]
2011     NIHR Health Technology Assessment programme Erlotinib monotherapy for the maintenance treatment of non-small cell lung cancer after previous platinum-containing therapy
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Criteria for indication and surgical treatment in Parkinson´s disease and epilepsy]
2011     NIHR Health Technology Assessment programme Etanercept, infliximab and adalimumab for the treatment of psoriatic arthritis: a systematic review and economic evaluation
2011     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Dissemination of HTA products. New lines of action]
2011     The Swedish Council on Health Technology Assessment (SBU) Treatment of hemophilia A and B and von willebrand disease
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Dabigatran etexilate for the prevention of stroke or systemic embolism in patients with non-vascular atrial fibrillation]
2011     Agency for Healthcare Research and Quality (AHRQ) Screening and treatment of subclinical hypothyroidism or hyperthyroidism
2011     NIHR Health Technology Assessment programme A pragmatic single-blind randomised controlled trial and economic evaluation of the use of leukotriene receptor antagonists in primary care at steps 2 and 3 of the national asthma guidelines (ELEVATE study)
2011     NIHR Health Technology Assessment programme Assessing the surgical skills of trainees in the operating theatre: a prospective observational study of the methodology
2011     NIHR Health Technology Assessment programme Mannitol dry powder for inhalation for the treatment of cystic fibrosis
2011     The Swedish Council on Health Technology Assessment (SBU) Medical and psychological methods for preventing sexual offences against children
2011     Unidad de Evaluacion de Tecnologias Sanitarias (UETS) [Systematic review of the effectiveness of the stereoscopic vision systems for minimally invasive surgery]
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Real time continuous glucose monitoring systems]
2011     Agency for Healthcare Research and Quality (AHRQ) Role of active surveillance in the management of men with localized prostate cancer
2011     NIHR Health Technology Assessment programme The RATPAC (Randomised Assessment of Treatment using Panel Assay of Cardiac markers) trial: a randomised controlled trial of point-of-care cardiac markers in the emergency department
2011     NIHR Health Technology Assessment programme Belimumab for the treatment of active autoantibody-positive systemic lupus erythematosus
2011     The Swedish Council on Health Technology Assessment (SBU) Computed tomography for suspected coronary artery disease
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Shoulder pain: appropriateness use of diagnostic imaging tests]
2011     NIHR Health Technology Assessment programme Palivizumab for immunoprophylaxis of respiratory syncytial virus (RSV) bronchiolitis in high-risk infants and young children: a systematic review and additional economic modelling of subgroup analyses
2011     NIHR Health Technology Assessment programme Fulvestrant for the treatment of locally advanced or metastatic breast cancer
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Long versus short acting drugs for attention deficit/hyperactivity disorder in children and adolescents: a review of the guidelines and recommendations
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Telephone-based counselling and home care as strategies to reduce the frequentation rate to hospital emergencies services: a review]
2011     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of different surveillance mammography regimens after the treatment for primary breast cancer: systematic reviews, registry database analyses and economic evaluation
2011     NIHR Health Technology Assessment programme Ofatumumab for the treatment of chronic lymphocytic leukaemia in patients who are refractory to fludarabine and alemtuzumab: a critique of the submission from GSK
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Education classes for diabetes management: a review of the comparative clinical and cost-effectiveness
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Rosuvastatin (Crestor®)
2011     Catalan Agency for Health Information, Assessment and Quality (CAHIAQ -formerly CAHTA) [Unplanned hospital readmissions in Catalonia]
2011     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of long-term weight management schemes for adults: a systematic review
2011     NIHR Health Technology Assessment programme Omalizumab for the treatment of severe persistent allergic asthma in children aged 6-11
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Functional Electrical Stimulation (FES) for children with spinal cord injuries: a review of the clinical effectiveness and guidelines
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Paliperidone palmitate (Xeplion®)
2011     NIHR Health Technology Assessment programme The clinical effectiveness and cost-effectiveness of bortezomib and thalidomide in combination regimens with an alkylating agent and a corticosteroid for the first-line treatment of multiple myeloma: a systematic review and economic evaluation
2011     NIHR Health Technology Assessment programme Ranibizumab for the treatment of macular oedema caused by retinal vein occlusion (RVO): a single technology appraisal
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Glyburide, gliclazide or glimepiride in the elderly with type 2 diabetes: a review of the clinical effectiveness and safety
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Dasatinib (Sprycel®)
2011     NIHR Health Technology Assessment programme EVerT: cryotherapy versus salicylic acid for the treatment of verrucae - a randomised controlled trial
2011     NIHR Health Technology Assessment programme Trabectedin for the treatment of relapsed ovarian cancer
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Fluticasone furoate versus fluticasone propionate for seasonal allergic rhinitis: a review of the clinical and cost-effectiveness
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tapentadol prolonged release (Palexia® SR)
2011     NIHR Health Technology Assessment programme Accuracy of bacterial DNA testing for central venous catheter-associated bloodstream infection in children with cancer
2011     NIHR Health Technology Assessment programme Roflumilast for the management of severe chronic obstructive pulmonary disease
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Antiplatelet agents for acute coronary syndrome: a review of the guidelines and recommendations
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Alteplase (Actilyse® Cathflo® 2 mg)
2011     NIHR Health Technology Assessment programme Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation
2011     NIHR Health Technology Assessment programme Trastuzumab for the treatment of HER2-positive metastatic adenocarcinoma of the stomach or gastro-oesophageal junction
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Calibration of blood glucose monitors for diabetes: a review of the clinical evidence and guidelines
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Saxagliptin (Onglyza®)
2011     NIHR Health Technology Assessment programme Hysterectomy, endometrial ablation and Mirena for heavy menstrual bleeding: a systematic review of clinical effectiveness and costeffectiveness analysis
2011     NIHR Health Technology Assessment programme Bevacizumab in combination with a taxane for the first-line treatment of HER2-negative metastatic breast cancer
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Venous thromboembolism prophylaxis for major general surgery: a review of the clinical effectiveness and guidelines
2011     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for triple negative adjuvant breast cancer; in combination with taxane and/or anthracycline chemotherapy
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sodium valproate (Episenta®)
2011     NIHR Health Technology Assessment programme The clinical effectiveness and safety of prophylactic retinal interventions to reduce the risk of retinal detachment and subsequent vision loss in adults and children with Stickler syndrome: a systematic review
2011     NIHR Health Technology Assessment programme A systematic review and economic evaluation of cilostazol, naftidrofuryl oxalate, pentoxifylline and inositol nicotinate for the treatment of intermittent claudication in people with peripheral arterial disease
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Amisulpride for adults with refractory schizophrenia: a review of the clinical effectiveness and safety
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Collagenase Clostridium histolyticum (Xiapex®)
2011     NIHR Health Technology Assessment programme MAVARIC - a comparison of automation-assisted and manual cervical screening: a randomised controlled trial
2011     NIHR Health Technology Assessment programme Prucalopride for the treatment of chronic constipation in women in whom laxatives fail to provide adequate relief
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) The association between obesity, aboriginal or indigenous people, indian or alaskan natives living in North America and residence in remote locations and severe outcomes with seasonal and pandemic influenza: a review of the clinical evidence
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tenofovir disoproxil fumarate (Viread®)
2011     Agenzia sanitaria e sociale regionale, Regione Emilia-Romagna (ASSR) Criteria for appropriate use of FDG-PET in breast cancer
2011     NIHR Health Technology Assessment programme Growth monitoring for short stature: update of a systematic review and economic model
2011     Medical Advisory Secretariat (MAS) Endovascular radiofrequency ablation for varicose veins: an evidence-based analysis
2011     Canadian Agency for Drugs and Technologies in Health (CADTH) Preoperative skin antiseptic preparations and application techniques for preventing surgical site infections: a systematic review of the clinical evidence and guidelines
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Histamine dihydrochloride (Ceplene®)
2011     NIHR Health Technology Assessment programme Processes in recruitment to randomised controlled trials of medicines for children (RECRUIT): a qualitative study
2011     NIHR Health Technology Assessment programme Clopidogrel and modified-release dipyridamole for the prevention of occlusive vascular events (review of Technology Appraisal No. 90): a systematic review and economic analysis
2011     Medical Advisory Secretariat (MAS) Diurnal tension curves for assessing the development or progression of glaucoma: an evidence-based analysis
2011     Medical Advisory Secretariat (MAS) Constraint induced movement therapy for rehabilitation of arm dysfunction after stroke in adults
2011     NIHR Horizon Scanning Centre (NIHR HSC) Cetuximab (Erbitux) in combination with oxaliplatin, leucovorin and fluorouracil for colorectal cancer - adjuvant
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Sunitinib (Sutent®)
2011     Andalusian Health Technology Assessment Area (AETSA) [Guidelines to produce citizen-friendly health technology assessment reports]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Cetuximab (Erbitux) in combination with capecitabine and cisplatin for advanced or metastatic gastric cancer – first line
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ferric carboxymaltose (Ferinject®)
2011     NIHR Health Technology Assessment programme Clinical effectiveness and cost-effectiveness of imatinib dose escalation for the treatment of unresectable and/or metastatic gastrointestinal stromal tumours that have progressed on treatment at a dose of 400 mg/day: a systematic review and economic evaluation
2011     NIHR Health Technology Assessment programme Golimumab for the treatment of psoriatic arthritis
2011     Andalusian Health Technology Assessment Area (AETSA) [Effectiveness and safety of the HELICA technique in the treatment of endometriosis. Systematic review of the literature]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Dasatinib (Sprycel) for prostate cancer – in combination with docetaxel
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Valganciclovir (Valcyte®) tablets
2011     Andalusian Health Technology Assessment Area (AETSA) [Vaccine against Neisseria meningitidis serogroup B]
2011     NIHR Horizon Scanning Centre (NIHR HSC) EC145 for folate receptor positive ovarian cancer
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Valganciclovir (Valcyte®) powder for oral solution
2011     National Institute for Health and Care Excellence (NICE) moorLDI2-BI: a laser doppler blood flow imager for burn wound assessment. NICE medical technologies guidance 2
2011     NIHR Health Technology Assessment programme Evidence Review Group approaches to the critical appraisal of manufacturer submissions for the NICE STA process: a mapping study and thematic analysis
2011     Andalusian Health Technology Assessment Area (AETSA) [Botulinum toxin A in the treatment of morbid obesity]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Erlotinib (Tarceva) in combination with sorafenib (Nexavar) for unresectable, advanced or metastatic hepatocellular carcinoma – first line
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Capecitabine (Xeloda®)
2011     The Netherlands Organisation for Health Research and Development (ZonMw) [Psychological treatment of personality disorders: a multi-centered randomised controlled trial on the (cost-)effectiveness of schema-focused therapy]
2011     Basque Office for Health Technology Assessment (OSTEBA) [Proposed health survey of the Basque Country for institutionalised population in nursing homes (ESCAV-IR). CAPV 2010]
2011     Andalusian Health Technology Assessment Area (AETSA) [Effectiveness and safety of percutaneous treatment of pelvic ring fractures]
2011     NIHR Horizon Scanning Centre (NIHR HSC) Heat-activated liposome encapsulated doxorubicin (ThermoDox) for hepatocellular carcinoma – first line
2011     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tacrolimus (Advagraf®)
2011     NIHR Health Technology Assessment programme Development and evaluation by a cluster randomised trial of a psychosocial intervention in children and teenagers experiencing diabetes: the DEPICTED study
2011     Norwegian Knowledge Centre for the Health Services (NOKC) [Treatment of chronic fatigue syndrome CFS/ME]
2011     Andalusian Health Technology Assessment Area (AETSA) [Effectiveness and safety of active immunotherapy against telomerase in solid-organ cancer]